by Sam Eskandari | Jul 12, 2017 | News
July 11, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce the appointment of RwE Growth Partners, Inc. to evaluate the Company’s $1.50 million investment...
by Lui Franciosi | Jul 10, 2017 | News
July 10, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce that its research arm, Cannevert Therapeutics Ltd. (CTL) will be sending a team overseas next week...
by Sam Eskandari | Jul 10, 2017 | News
July 10th, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that it is preparing to begin construction of a state-of-the-art cannabis growing facility upon receiving Health Canada’s license under Access to...
by Sam Eskandari | Jun 6, 2017 | News
June 6, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), as an ACMPR applicant would like to notify its investors that Health Canada is introducing several improvements that aim to streamline the ACMPR licensing process....
by Sam Eskandari | May 30, 2017 | News
May 30, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that Cannevert Therapeutic Ltd.’s development of its medicinal cannabis pipeline has expanded to include anti-emesis (anti-nausea/vomiting) therapies....
by Sam Eskandari | May 17, 2017 | News
May 17, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce the appointment of David Greenway as a Director of the Company. Mr. Greenway has two decades of...
by Sam Eskandari | May 8, 2017 | News
May 8, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce that its research arm, Cannevert Therapeutics Ltd. is moving swiftly towards properly certified and...
by Lui Franciosi | Apr 21, 2017 | News
April 21, 2017, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) announces that, further to its December 21, 2015 and October 5, 2016 news releases, it has paid the final installment for its acquisition of 80%...
by Lui Franciosi | Apr 18, 2017 | News
April 18, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce that CEO and President, Dr. Lui Franciosi will present at The Planet Microcap Showcase 2017...
by Sam Eskandari | Mar 14, 2017 | News
March 15, 2017, Vancouver, B.C. – Veritas Pharma Inc. “Veritas” (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce that it has entered into an agreement with AlphaPheno Inc....
